Background: Over the past decade, there has been recognition of the importance of the human microbiome. Beyond improved microbial cataloguing through highthroughput genetic sequencing, we have learned that human beings are superorganisms integrating the identity, function and immunity of resident bacterial, while prepared throughout own innate and adaptive immune systems, to deal with invading organisms. Hypothesis: In keeping with the dynamic relation of infection, immunity and inflammation contained in I-Cubed, illness arises when protective immunity becomes the source of autoimmunity, conditioned by environmental and genetic factors. Results: This paradigm explains the etiopathogenesis of diverse medical (type 1 diabetes, spondyloarthropathy), neurologic (Lyme neuroborreliosis), and neuropsychiatric disorders (PANDAS, and autism spectrum disorders). Conclusion: Successful treatments employing immune-modulatory therapy may be employed. Public health officials will be called upon to guide the public's understanding and mitigate the risk of disorders that result from the interplay of the human microbiome and I-Cubed.
Introduction
The human microbiome, defined as the collection of microorganisms that reside within our body, has coevolved over the history of mankind, and has been overlooked as determinants of health and disease. Given the appearance of new microbial agents and the everyday occurrence of unexplained lethal neurological syndromes of suspected infec-tious etiology, scientists have begun to identify a plethora of microbial agents in our body and in the human genome. The true capability of such microbes residing in our body to cause human disease has become the focus of medical science. Post-infectious autoimmune illness is increasingly recognized due to resident and invasive microbial agents that have the capacity to trigger our immune system, turning it on and off at will. With differences in resident microbial niches, imperfect host defenses, and susceptibility to epidemic and endemic diseases in the environment, there are ever increasing opportunities for bacterial, virus, and parasitic exposures.
The triumvirate rate of infection, immunity and inflammation, abbreviated as I-Cubed (I 3 ), posits that complex self-sustaining responses from infectious insults to the nascent immune system, whether by contagious or innate sources endemic to ones' microbiome, may explain the etiopathogenesis of diverse medical, neurologic and neuropsychiatric disorders, notably type 1 diabetes (T1D), spondyloarthropathy (SpA), Lyme neuroborreliosis (LNB), pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS), and autismspectrum disorders (ASD).
Underlying genetic vulnerability, pre-and post-natal factors and individual differences in exposure timing and host immune responses may further explain differences in eventual outcome. Innovative therapeutic strategies involving immune modulation may be effective in some affected patients.
The public health community needs to be aware of the advances in the human microbiome and its interplay with autoimmunity in order to effectively provide surveillance and communication to different potential groups of users to whom they refer, and to mitigate the risk to society [1] .
Human Microbiome
For an appreciation of the human microbiome, imagine the excitement of a scientist at a medical conference claiming to have discovered a new human organ which likes the immune system, contains collections of cells and a 100-times more genes than the host.
Not only is it tailored to the individual host, but it is modifiable by stress, diet, medications, exercise, and antibiotics. When lost, nearly all aspects of the host's normal physiological function are altered. Although it has been known for some time that the human body is inhabited by resident flora in a factor greater than 10:1, Most researchers have focused instead on a minority of disease-causing or "pathogenic" organisms with far fewer examining the benefits of the resident bacterial flora.
The concept of the human microbiome or microbiota originated with the Rockefeller University scientist Joshua Lederberg [2] as an ecological community of commensal, symbiotic, and pathogenic microorganisms sharing our body space. It is estimated that 20% to 60% of the human-associated microbiome, depending on body site, is still resistant to conventional culture techniques making it difficult to accurately estimate its true diversity. More recently, the human microbiome has been studied in different biological states using gene sequencing techniques. Scientists have used molecular tools to extract and compare bits of a particular kind of ribonucleic acid (RNA) the products of deoxyribonucleic acid (DNA) transcription and translation, to determine if previously known or new microbes were present in a particular human tissues such as blood. This technique which is widely used as a biomarker for microbial disease uses a particular kind of RNA known as 16S ribosomal RNA (rRNA). Since the genes for ribosomal RNA have changed little over millions of years as organisms have evolved, slight changes in their composition provide valuable clues to the very nature of microbial organisms located in the human body. The 16S rRNA gene is very short, just 1542 nucleotide bases making it quickly and cheaply copied, sequenced and then compared to libraries of stored 16S rRNA genes from numerous known bacteria. The ones that match up perfectly are microbes that have been previously identified while others that show differences may be previously unknown microbes. Such studies of gastrointestinal microbes at the 16S rRNA gene level have revealed significant diversity in the flora of individuals. We are presently at a public health crossroads, in a position to make gigantic gains in our knowledge to better understand how microbes impact on human health, transitioning from description to causality and microbial engineering. Underscoring this, two papers published simultaneously in the journals Science [3] and Nature [4] With more than 90% of cells in the human micobiome understood to be bacterial, viral, parasitic, fungal or otherwise non-human in nature, and human metabolism and immunity attributed to the molecular genetic contribution of microbial and human interaction, human beings are being referred to as superorganisms. In the last decade the United States (U.S.) Human Microbiome Project and European MetaHit, two largescale genomic projects, along with several private efforts, have investigated the microbiota in a variety of human body niches using new molecular genetic tools. While many sites such as the skin, oral and nasal cavities, and vagina are all relatively easy to access, the majority of research in this area has focused on the gastrointestinal tract, in particular the colon. A newly recognized axis of communication between the gut and brain has led to the recognition of a mind-gut connection attempts to explain the spectrum of functional symptoms from anxiety and depression to irritable bowel syndrome (IBS).
With five phyla representing the majority of bacteria that comprise the gut microbiota, there are about 160 species in the large intestine alone of any individual, and very few of these are shared between individuals. The functions contributed by these species appear to be found in everybody's gastrointestinal tract, an observation that suggests that microbial function is more important than the identity of the species providing it. Our understanding of human microbial biology first derived from pure cultures and genomic sequencing, has been limited by sampling bias toward four bacterial phyla, Proteobacteria, Firmicutes, Actinobacteria and Bacteriodes, out of the 35 bacterial and 18 known archael phylum-level lineages. With roughly two-thirds of published microbiological research dedicated to only eight bacterial genera, all of which grow well on agar culture plates, it is unlikely that they are representative of the 5000 or more species known to us.
I-Cubed: Infection Activates Immunity
Immunity was historically understood for its purported effects due to active immunization. The first type was the effect of immunization that resulted in definable changes in the cell-free bodily fluid or serum or humor while another was the observed protective Not surprisingly, major understandings of the pathophysiology of autoimmune diseases have been achieved through an appreciation of infectious triggers of the humoral and cell-mediated immune system. When first identified as the causative agent of the neurological disorder, Whipple disease almost 25 years ago by Relman and coworkers [5] , it was unclear whether the uncultured bacillus Tropheryma (T.) whippelii was a rare member of the normal human microbial flora and whether it might be associated with other human diseases. Whipple disease causes a systemic infection which unrecognized and therefore untreated, involves the gastrointestinal tract, heart, and brain.
According to phylogenetic analysis the isolated bacterium was a gram-positive Actinomycetes not closely related to any known genus. A molecular genetic approach amplifying a 16SrRNA sequence directly from tissues of five unrelated patients determined its nucleotide sequence. A decade later, the same authors [6] performed ultrastructural studies of intestinal biopsy specimens from affected patients. These studies showed the location of T. whippelii rRNA to be most prevalent near the tips of the intestinal villi in the lamina propia just basal to the epithelial cells, located between cells and not intracellular indicating that the bacillus grew outside cells and that it was not an obligate intracellular pathogen. Such studies ushered in a generation of molecular genetic technology used today in the study of resident human microbes.
Relman [7] observed that molecular, cultivation-independent methods revealed that the distribution and diversity of microorganisms in the world was far greater than previously appreciated. One particular molecular genetic technique compared humantissue derived DNA sequences with those of known pathogenic and commensal bacterial, viral, fungal and protozoan genomes in established expressed-sequence tag libraries. However, inefficient and cost-ineffective for screening large numbers of specimens in most laboratories has revealed surprising findings of nonhuman genetic sequences that appeared to be an inherent feature of the human genome. For example, it appears that all humans have human endogenous retrovirus sequences as an integral part of their genome [8] . At some time during the course of human evolution, exogenous progenitors of the human endogenous retrovirus inserted itself into the human germ-line reproductive cells where they were replicated along with the host cellular genes. However intact disease-producing retroviruses differ in the presence of at least one additional coding region, the env gene that encodes viral membrane proteins that mediate the budding of virus particles to the cellular receptors enabling virus entry as the first step in the pathway to a new replication cycle and disease pathogenicity.
Hajjeh and coworkers [9] observed that unexplained deaths and critical illness possibly due to infectious causes in previously healthy persons occurred at an incidence rate of 0.5 per 100,000 per year from 1995 to 1998 among 7.7 million persons in four U.S.
Emergency Infectious Programs. However, only two-thirds of which were diagnosed by reference serological tests and the remaining one-third by PCR based methods. These findings suggested the need for molecular genetic surveillance approaches to detect present and emerging infectious diseases. New molecular biological techniques have led to the identification of several previously unculturable infectious agents such as non-A and non-B hepatitis, and hantavirus [10] . The effects of these bacteria on the production of interleukin (IL)-8, a proinflammatory chemokine, were also measured. F. nucleatum adheres to, and invades human gingival epithelial cells accompanied by high levels of IL-8 secretion from the epithelial cells [11] . By electron microscopy, this invasion occurs via a zipping mechanism that requires the active involvement of actins, microtubules, signal transduction, protein synthesis, and energy metabolism of the human gingival epithelial cells, as well as protein synthesis by F. nucleatum.
Other investigators [12] noted a heightened risk of inflammatory bowel disease (IBD), SpA, and colorectal cancer (CRC) between diffusely adherent Eschericia coli and areas of dysplastic mucosa of the colon that made it easier for the bacterial pathogens to gain direct contact with the mucosal surface, a location that is relatively sterile in the normal colon. This allowed interaction between bacterial components and intrinsic Tcell receptors of the human mucosa with subsequent downstream protein signaling as the mechanism for early oncogenesis illustrating yet another molecular genetic property of the resident bacteria in their putative role in genotoxicity and human disease. If epithelial-associated bacteria play a causative role in IBD and colorectal cancer, then dietary consumption of soluble plant fibers that prevent mucosal recruitment of bacteriamay be protective against both conditions. Post-infectious autoimmunity is a recognized phenomenon with several theories to explain its occurrence including molecular mimicry, bystander activation, and viral persistence [13] . Alone or in combination, these mechanisms have been used to account for the immunopathology observed at the site of infection and in distant areas of the body. Molecular mimicry occurs when there are shared immunologic identities or epitopes between the microbe and host. One well recognized example is rheumatic fever, a systemic autoimmune disease that occurs after GABHS infection wherein affected patients develop and manifest circulating antibodies to the bacterial organism reactive to the heart, joint, and brain leading to the cardinal manifestations of rheumatic fever.
Pediatric autoimmune neuropsychiatric disease associated with GABHS infection is
another example of bacterial-based molecular mimicry. There is a reciprocal dynamic between the central nervous system (CNS) and immune system, conditioned by the microbiome that regulates a cross-talk [14] 
Medical Disorders

Spondyloarthropathy
The relationship between microbial infection and the gut which has been known for decades as the basis for the SpA [16] has only recently been incorporated into the I-Cubed paradigm. SpA consists of diverse disorders of inflammatory arthritis. The reported incidence of 0.48 to 63/100,000 and prevalence of 0.01% to 2.5% for SpA diseases in the population [17] varying depending upon on the methodology and case definitions used for case ascertainment, and frequency of HLA-B27 in the population studied. Affected patients with symptoms referable to the vertebral column and limb joints may be seen by a variety of specialists including rheumatologists, neurologists, and general practitioners before the disorder is correctly diagnosed. Documentation of the HLA B27 haplotype is a frequent associated feature. Experimentally-induced SpA occurs in mice with a striking resemblance to humans when HLA B27 components are introduced into genetically susceptible animals establishing its central role in the human sickness [18] . Certain genetically-prone mice develop colitis and later SpA when they are colonized with Bacterioides flora along with increased colonic cytokine expression compared to germ-free animals [19] . The story however became more interesting when it was found that such animals also showed activation of Th17 helper cells [20] with HLA-B27 misfolding and a further heightened immune response to the unfolded protein associated with interleukin-23 production [21] . Taken together, these findings suggested that genetically predisposed animals react to a microbial imbalance by altering their immune system in the intestinal compartment toward a more inflammatory state. The process is mediated by T-cell and interleukin production which ultimately leads to local and systemic clinical disease manifested as a SpA-like human illness [22] .
Such insights of the microbiomes have been used to advance therapy of SpA and other autoimmune arthritides. Empiric broad spectrum antibiotics do not appear to have a therapeutic role and may selected species with even more pathogenic potential. Bacterial modulation using alternative methods drawing from innate benefits of the microbi-ota [23] such as fecal microbial transplantation, diet and probiotics have instead been employed to restore a healthier intestinal microbiome.
Type 1 Diabetes Mellitus
T1D is associated with diverse metabolic processes that stem from hyperglycemia due to deficient secretion or action of insulin rendering them at perpetual risk for secondary neuropathic, ophthalmologic, renal and vascular disease. T1D usually develops before age 30 years and such individuals need insulin injections for the rest of their life.
Their disease is caused by the gradual loss of insulin producing β-cells in the pancreas [24] . Patients with T2D are typically older, often obese, and at high risk for hypercholesterolemia and heart disease, with relative insulin resistance that perpetuates hyperglycemia. The epidemiology of diabetes is well known. In the U.S. alone, more than one million people are living with T1D and approximately 80 people per day, or 30,000 individuals per year, are newly diagnosed. The global incidence of T1D is increasing at a rate of approximately 3% to 4% per year, notably among younger children. These statistics highlight the need for both better TID therapies and the continued push towards the prevention of T1D.
In the past several years, several lines of investigations have suggested the importance of environmental factors including infectious diseases making T1D an important candidate for an I-Cubed framework of understanding:
First, T1D appears to be caused by autoimmune mechanisms directed against the insulin-producing β-cells of the pancreas [25] with up to 90% of T1D patients harboring or more autoantibodies.
Second, the pancreas of newly diagnosed T1D patients shows inflammation of the pancreas in the region of the insulin producing β-cells [26] .
Third, the possibility that the onset of T1D might be triggered in genetically predisposed individuals by a preceding infection inducing attack on islets by molecular mimicry was investigated in T1D children who died prematurely. Their autopsy showed pancreatic islet cell, membrane-bound, superantigens indicating integrated bacterial or viral genes. The genetic risk of T1D is strongly linked to HLA class II DR3 and DR4 haplotypes, with the highest risk in those with the DR3/DR4 genotype. The importance of HLA genes to T1D risk highlights the role of the adaptive immune system in the development of autoimmunity.
Fourth, T1D occurs with increased frequency in association with several other autoimmune disorders, including Grave disease, pernicious anemia, Hashimoto thyroiditis, myasthenia gravis, anti-phospholipid antibody syndrome, and Addison disease. suggesting that molecular mimicry may be the priming event in the destruction of β-islet cells in animals and humans [27] . Moreover, the response of T-cells to homologous peptides derived from microbial antigens suggests that their initial priming could occur via molecular mimicry.
Sixth, it is hypothesized that perturbations in normal early microbiome development might pre-dispose to disease whether through direct modulation of innate immunity or via alteration of intestinal permeability, with a downstream effect on adaptive immunity. The gut microbiome is both less diverse and protective in individuals with islet cell autoimmunity or recent onset T1D [28] - [31] . Whether this difference is causal to T1D in such patients is not known since multiple factors could affect the early intestinal microbiome, some of which also have been shown to correlate with risk of islet autoimmunity and T1D [32] . Nevertheless, increased intestinal permeability as a consequence of prolonged enteric intestinal infections could lead to increased susceptibility to T1D [24] . killing of β-cells [33] . Whatever the etiopathogenesis, there is a public health urgency to reduce the neuropathic, ophthalmologic, renal and vascular complications of T1D.
Lyme Neuroborreliosis
Lyme disease in humans is caused by the transmission of Borrelia (B.) [48] found no differences between affected cases and controls in absolute NAA in whole brain or when gray and white matter were considered separately within the voxels of interest using a mixed model of analysis of variance (ANOVA). However, brain FDG-based proton-emission tomography (FDG-PET) useful in the evaluation of cognitive and memory disturbances in affected patients with LE, disclosed two patterns, temporal and parieto-temporal lobe hypometabolism and diffuse cortical hypometabolism, in which temporal lobe involvement was an important associated feature of the memory disturbance [49] . The close coupling of regional cerebral blood flow (rCBF) and cerebral metabolic rate (rCMR) in other affected patients enrolled in a case-control study of LE [50] that found no difference between study patients and controls in measurements of resting rCBF and rCMR except after hypercapnia challenge, nonetheless suggested that the observed regional abnormalities were primarily metabolically driven.
MRI combined with PET imaging more effectively displays the area of hypometabolism in LNB nor has it been adequately studied in well-defined cohorts of LNB.
PANDAS
Between [56] which attaches to the surface of B cells as a susceptibility factor for rheumatic fever, has been noted in 85% of patients with PANDAS, yet in only 17% of normal controls [57] . The GNcNAc epitope expressed in SC monoclonal antibodies (mAb) provokes a strong humoral response during and after active streptococcal infection [58] [59] as a result of terminal O-linked GLcNAc residues that show structural similarity to host glycoconjugates. Moreover, experimental animals immunized with GlcNAc mAb leads to a T-cell dependent specific antibody response [60] . Anti-ganglioside antibodies mediate signal transduction pathways in cultured neuroblastoma cells [61] [62] and trigger calcium/calmodulin-dependent protein (CaM) kinase II activation [58] . Active 
Autism
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior [70] . Autism spectrum disorder is a broader phenotype encompassing the less severe disorders Asperger syndrome and PDD not [81] . A later population-based study [82] and a recent meta-analysis of case-control and cohort studies [83] found no strong evidence for an association between autism and MMR vaccination.
A case-control study [84] found that vaccinated children with autism and gastrointestinal disturbances were no more likely than age-matched children undergoing clini- [85] were at significantly increased odds of maternally reported gastrointestinal disturbances including constipation, food allergies, food intolerance, diarrhea, and constipation. Although the early reports of Wakefield and colleagues [76] - [78] may have muddied the waters considerably, there has been subsequent evidence of alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives [86] and inflammation in the gastrointestinal tract of children with ASD including immune cell infiltrates in the small and large intestine, as well as increased T-cell activation in the intestinal mucosa compared to controls, that contribute to decreased mucosal integrity or leaky gut [67] . Active maternal infection and maternal immune activation in the absence of a pathogen lead to cardinal symptoms of autism in affected offspring of immune-activated dams in experimental animal models of childhood autism [88] [89].
Apart from the impact of infection and autoimmunity, autism has been associated with maternal age >35 years alone [90] or in those with foreign citizenship, use of medications during pregnancy, and among children with low birth weight and congenital malformations [91] ; slowly advancing [92] or 10-year increased in maternal and paternal age [93] , paternal age >40 years and being first-born of two older parents [94] ; underlying genetic factors and obstetric complications [95] ; maternal disease exposure to drugs, substance abuse, folic acid deficiency; pesticides, and air pollution [96] . The Autism Birth Cohort (ABC) [97] was established to address the natural history of ASD and to explore genetic and pre-or perinatal environmental factors in causation, as well as the interplay between genes and environment, and to facilitate discovery of biomarkers with potential to enable early recognition and treatment.
Current thinking now is that multiple potential risk factors, maternal, pre-and post-natal, and environmental including inflammatory autoimmune insults superimposed upon a genetically vulnerable substrate, can trigger the aberrant neuronal development characterizing autism. In support of the latter is absence of postmortem and neuroimaging signs of neurodegeneration in affected cases [98] . 
Conclusion
Medical science is just now realizing the full importance of the microbial world. Thanks to genetic advances such as low-cost high-throughput sequencing of microbial communities comprising the human microbiome, the identity and function of unculturable microbes is being unveiled. Beyond improved microbial cataloguing, we are learning that human beings are superorganisms integrating the identity, function, and immunity of resident bacteria, yet prepared throughout our own innate and adaptive immune systems and modified by genetic and environmental factors, to deal with invading organisms. Protective immunity becomes the source of autoimmunity through a variety of well-established mechanisms. Public health officials and neuroepidemiology researchers will be called upon to guide the understanding of I-Cubed illnesses and the implications of the human microbiome for communicable and non-communicable diseases, at times one leading to the other, as the natural history is appreciated and the responsiveness of given medical and neurological disorder to a variety of medical approaches including strong antibiotics and immune-modulatory is established
